Business Wire

Soterix Medical, Inc. Announces tDCS-LTE Depression Treatment Partnership Program for Clinicians and Medical Centers based on its Non-invasive Neuromodulation Platform

NEW YORK--(BUSINESS WIRE)--Soterix Medical, Inc. announced today that it is seeking physicians and clinical centers across the European Union (EU) to join its tDCS-LTE™ Depression Treatment ...
dailyfreeman.com

NYU Langone Health Launches At-Home Virtual Brain Stimulation Program

NEW YORK, May 26, 2021 /PRNewswire/ — NYU Langone Health today announced a new at-home service for transcranial direct current stimulation (tDCS)-a type of noninvasive brain stimulation-currently ...
Medscape

Targeted tDCS Linked to Improved Depression Symptoms

Personalized high-definition transcranial direct current stimulation (HD-tDCS) administered over 12 days was associated with a greater improvement in depression and anxiety symptoms in patients with ...
WTEN

Soterix Medical announces Phase-2 trial to test at-home tDCS paired with cognitive training as a therapeutic option for long COVID

WOODBRIDGE, N.J. and NEW YORK, Aug. 28, 2023 /PRNewswire/ -- Soterix Medical Inc. announces the launch of a Phase-2 clinical trial that will evaluate the combination of REMOTE-tDCS and a brain ...